Clinical Value of G-EYE Colonoscopy in Daily Practice for Adenoma Detection and Time for Polyp Removal

October 21, 2021 updated by: Prof. Dr. Ralf Kiesslich, Dr. Horst Schmidt Klinik GmbH
Colonoscopy parameters will be compared before the introduction of the G-EYE endoscope and after the introduction of the G-EYE endoscope

Study Overview

Detailed Description

Colonoscopy parameters such as demographics, findings and procedural times will be compared before the introduction of the G-EYE endoscope and after the introduction of the G-EYE endoscope

Study Type

Observational

Enrollment (Actual)

2795

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Wiesbaden, Germany
        • Helios Dr. Horst Schmidt Kliniken

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Screening and surveillance colonoscopy patients

Description

Inclusion Criteria:

- Indication for screening or surveillance colonoscopy based on the German guideline for colon cancer screening

Exclusion Criteria:

  • Emergency procedure
  • Patients with known inflammatory bowel diseases
  • Patients with hereditary cancer syndromes
  • Patients with acute colonic inflammation (e.g. diverticulitis, ischemic colitis)
  • Patients after radiation of the abdomen or pelvis
  • Patients with colonic surgery (except appendectomy)
  • Patients with incomplete colonoscopy
  • Patients with insufficient bowel preparation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Standard Colonoscopy
Colonoscopy with a standard colonoscope
Colonoscopy with a standard colonoscope
G-EYE® Colonoscopy
Colonoscopy with a G-EYE Colonoscopy
Colonoscopy with a G-EYE Colonoscope

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Detection rate - measured by adenoma detection rate (% subjects having at least 1 adenoma)
Time Frame: February 2021
G-EYE® colonoscopy adenoma detection rate compared to adenoma detection rate of standard colonoscopy
February 2021
Effectiveness of intervention - measured by polyp removal time (mm:ss)
Time Frame: February 2021
G-EYE® colonoscopy polyp removal time compared to polyp removal time of standard colonoscopy
February 2021

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2020

Primary Completion (Actual)

April 1, 2021

Study Completion (Actual)

May 1, 2021

Study Registration Dates

First Submitted

February 18, 2021

First Submitted That Met QC Criteria

February 21, 2021

First Posted (Actual)

February 23, 2021

Study Record Updates

Last Update Posted (Actual)

October 22, 2021

Last Update Submitted That Met QC Criteria

October 21, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • G-EYE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adenoma

Clinical Trials on Standard Colonoscopy

3
Subscribe